Summit Investment Advisors »

Bridgebio Pharma shares owned by Summit Investment Advisors

Quarter-by-quarter ownership of Bridgebio Pharma (BBIO) shares owned by Summit Investment Advisors from 13F filings

Historical chart of Summit Investment Advisors investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Summit Investment Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $466k 12k 40.37
2023-09-30 $300k 11k 26.37
2023-06-30 $163k 9.5k 17.20
2023-03-31 $136k 8.2k 16.58
2022-12-31 $70k 8.2k 8.52
2022-09-30 $81k 8.2k 9.88
2022-06-30 $74k 8.2k 9.02
2022-03-31 $83k 8.2k 10.12
2021-12-31 $137k 8.2k 16.71
2021-09-30 $395k 8.4k 46.81
2021-06-30 $514k 8.4k 60.91
2021-03-31 $471k 7.7k 61.54
2020-12-31 $441k 6.2k 71.06
2020-09-30 $233k 6.2k 37.54
2020-06-30 $211k 6.5k 32.57
2020-03-31 $188k 6.5k 29.02
2019-12-31 $66k 1.9k 35.14
2019-09-30 $40k 1.9k 21.30